These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 15136228

  • 1. e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease?
    Colla S, Sammarelli G, Voltolini S, Crugnola M, Sebastio P, Giuliani N.
    Haematologica; 2004 May; 89(5):611-3. PubMed ID: 15136228
    [Abstract] [Full Text] [Related]

  • 2. [Detection and quantification of BCR-ABL transcripts in patients with chronic myeloid leukemia by real-time quantitative reverse transcriptase polymerase chain reaction].
    Xing W, Gu BW, Zhu YM, Jiang CL, Zhao RH, Wang AH, Sun HP, Li JM, Shen ZX, Chen Z, Chen SJ.
    Zhonghua Yi Xue Za Zhi; 2005 Feb 23; 85(7):453-7. PubMed ID: 15854550
    [Abstract] [Full Text] [Related]

  • 3. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
    Vefring HK, Gruber FX, Wee L, Hovland R, Hjorth-Hansen H, Gedde Dahl T, Meyer P.
    Acta Haematol; 2009 Feb 23; 122(1):11-6. PubMed ID: 19641300
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Delayed cytogenetic response with prolonged interferon-alpha treatment in chronic myeloid leukemia patients: quantification of BCR-ABL transcript by competitive reverse transcription-polymerase chain reaction.
    Perego RA, Nosari AM, Cornacchini G, Bianchi C, Corizzato M, Morra E.
    Haematologica; 2001 Oct 23; 86(10):1101-3. PubMed ID: 11602419
    [No Abstract] [Full Text] [Related]

  • 7. p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?
    Roumier C, Daudignon A, Soenen V, Dupriez B, Wetterwald M, Lai JL, Cosson A, Fenaux P, Preudhomme C.
    Haematologica; 1999 Dec 23; 84(12):1075-80. PubMed ID: 10586207
    [Abstract] [Full Text] [Related]

  • 8. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
    Chelysheva EIu, Turkina AG, Misiurin AV, Aksenova EV, Domracheva EV, Zakharova AV, Khoroshko ND.
    Ter Arkh; 2007 Dec 23; 79(4):49-53. PubMed ID: 17564019
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Ten years of molecular monitoring of chronic myeloid leukemia by quantitative RT-PCR].
    Moravcová J, Brdicka R.
    Cas Lek Cesk; 2005 Dec 23; 144(1):32-7. PubMed ID: 15789779
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Study on relationship between different bcr/abl fusion transcripts and clinical manifestations in chronic myeloid leukemia].
    Qin YZ, Liu YR, Li JL, Wang H, Chang Y, Fu JY, Ruan GR, Qiu JY, Lu DP, Chen SS.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul 23; 24(7):347-50. PubMed ID: 12941187
    [Abstract] [Full Text] [Related]

  • 13. [Two Ph chromosome positive chronic myelogenous leukemia patients with rare bcr/abl fusion gene].
    Qin YZ, Liu YR, Li JL, Wang H, Chang Y, Fu JY, Ruan GR, Shi HL, Qiu JY, Lu DP, Chen SS.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul 23; 25(7):409-12. PubMed ID: 15355693
    [Abstract] [Full Text] [Related]

  • 14. Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samples.
    Stock W, Yu D, Karrison T, Sher D, Stone RM, Larson RA, Bloomfield CD.
    Int J Oncol; 2006 May 23; 28(5):1099-103. PubMed ID: 16596225
    [Abstract] [Full Text] [Related]

  • 15. A multiplex PCR for improved detection of typical and atypical BCR-ABL fusion transcripts.
    Burmeister T, Reinhardt R.
    Leuk Res; 2008 Apr 23; 32(4):579-85. PubMed ID: 17928051
    [Abstract] [Full Text] [Related]

  • 16. Relationship of the BCR gene breakpoint and the type of BCR/ABL transcript to clinical course, prognostic indexes and survival in patients with chronic myeloid leukemia.
    Prejzner W.
    Med Sci Monit; 2002 May 23; 8(5):BR193-7. PubMed ID: 12011769
    [Abstract] [Full Text] [Related]

  • 17. [Monitoring bcr/abl mRNA levels in imatinib mesylate treated chronic myeloid leukemia patients by real-time quantitative RT-PCR].
    Qin YZ, Ruan GR, Liu YR, Li JL, Fu JY, Wang H, Chang Y, Jiang B, Jiang Q, Jiang H, Qiu JY, Chen SS, Lu DP.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan 23; 26(1):1-5. PubMed ID: 15946498
    [Abstract] [Full Text] [Related]

  • 18. Monitoring molecular response by BCR-ABL, JH and WT-1 in Ph+ all treated with imatinib containing regimen: preliminary report of two cases.
    Miglino M, Varaldo R, Colombo N, Grasso R, Clavio M, Garuti A, Aquino S, Albarello A, Sessarego M, Gobbi M.
    J Exp Clin Cancer Res; 2006 Sep 23; 25(3):321-4. PubMed ID: 17167971
    [Abstract] [Full Text] [Related]

  • 19. Lymphoid preponderance and the absence of basophilia and splenomegaly are frequent in m-bcr-positive chronic myelogenous leukemia.
    Hur M, Song EY, Kang SH, Shin DH, Kim JY, Park SS, Cho HI.
    Ann Hematol; 2002 Apr 23; 81(4):219-23. PubMed ID: 11976825
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.